Eterna Therapeutics
ERNA
#10320
Rank
โ‚น0.89 B
Marketcap
โ‚น113.69
Share price
1.61%
Change (1 day)
-67.04%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): -โ‚น6,436

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น6,921. In 2022 the company made an earnings per share (EPS) of -โ‚น11,355 an increase over its 2021 EPS that were of -โ‚น75,019.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น6,436
2022-โ‚น11,355-84.86%
2021-โ‚น75,019

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Baxter
BAX
-โ‚น59.55-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น10.83-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-โ‚น182.26-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น334.35-104.83%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Techne
TECH
โ‚น45.11-100.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น56.84-100.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel